Xeris Pharmaceuticals erhält von der Europäischen Kommission die Zulassung für die Ogluo™-Injektion (Glucagon) zur Behandlung von schwerer Hypoglykämie bei Erwachsenen, Jugendlichen und Kindern ab 2 Jahren mit Diabetes mellitus | Business Wire
Weekly injection could treat type 2 diabetes, new enzyme discovery suggests
New diabetes treatment could eliminate need for insulin injections | Medical research | The Guardian
Type 2 diabetes: New biopolymer injection may offer weeks of glucose control
This New Treatment Could Provide Weeks of Glucose Control For Type 2 Diabetes Patients : ScienceAlert
RACGP - Semaglutide supplies return to Australia ahead of schedule
FDA Approves Higher Doses of Trulicity To Help People with Type 2 Diabetes
The European Commission Approves Sanofi and Zealand Pharma's GLP-1 Agonist Lyxumia (lixisenatide)
Ozempic: How a TikTok weight loss trend caused a global diabetes drug shortage - and health concerns | Euronews
Once-daily injection to treat type 2 diabetes - Clinical Advisor
The Dos and Don'ts of Insulin Injections - Type 2 Diabetes Center - Everyday Health
Tirzepatide (Mounjaro): A Q&A With the ADA's Dr. Robert Gabbay | Everyday Health
Type 2 Diabetes Drug Tirzepatide (Mounjaro) Aids Weight Loss in People With Obesity: Study | Everyday Health
FDA approves new kind of diabetes drug with anti-obesity potential
Insulin Pens for Diabetes: A Complete Scientific Guide | Everyday Health
Trulicity (Dulaglutide) - How do I use it and what does it do?
Lyumjev (insulin lispro-aabc) for Type 1 and Type 2 Diabetes
FDA Approves Mounjaro, a Novel Once-a-Week Medication to Treat Type 2 Diabetes | Everyday Health
FDA Approves Ozempic, A Powerful Once-Weekly Type 2 Diabetes Medication
Diabetes Patients Also Struggle to Access GLP-1 Agonists | MedPage Today
Once-a-week insulin for type 2 diabetes shows promise in early trial
The Science Behind Controversial New Weight Loss Drugs Like Ozempic
